Detalhe da pesquisa
1.
Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016-2020.
BMC Nephrol
; 25(1): 98, 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493085
2.
The risks associated with percutaneous native kidney biopsies: a prospective study.
Nephrol Dial Transplant
; 38(3): 655-663, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35587882
3.
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial.
J Am Soc Nephrol
; 32(4): 972-982, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649098
4.
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients.
Clin Chem Lab Med
; 59(9): 1516-1526, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915609
5.
Pathology and pathogenic pathways in fabry nephropathy.
Clin Exp Nephrol
; 25(9): 925-934, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768330
6.
Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis.
Mol Genet Metab
; 129(2): 132-141, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718986
7.
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Nephrol Dial Transplant
; 35(6): 1002-1009, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418652
8.
Cinacalcet in focal segmental glomerular sclerosis: a case report.
Kidney Int
; 105(2): 389-390, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245216
9.
Parapelvic cysts, a distinguishing feature of renal Fabry disease.
Nephrol Dial Transplant
; 33(2): 318-323, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28371803
10.
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
Int J Mol Sci
; 19(12)2018 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30477121
11.
Contribution of inflammatory pathways to Fabry disease pathogenesis.
Mol Genet Metab
; 122(3): 19-27, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947349
12.
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.
Neuroradiology
; 59(6): 563-570, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28386689
13.
Fabry's disease: an example of cardiorenal syndrome type 5.
Heart Fail Rev
; 20(6): 689-708, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26232292
14.
Extracapillary proliferation is an independent predictive factor in Immunoglobulin A nephropathy.
Nephrology (Carlton)
; 20(9): 654-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943286
15.
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
Kidney Int
; 86(4): 828-36, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24694989
16.
Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?
BMC Nephrol
; 15: 72, 2014 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886109
17.
The role of tubular cells in the pathogenesis of Fabry nephropathy.
Front Cardiovasc Med
; 11: 1386042, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646152
18.
Updated Evaluation of Agalsidase Alfa Enzyme Replacement Therapy for Patients with Fabry Disease: Insights from Real-World Data.
Drug Des Devel Ther
; 18: 1083-1101, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585254
19.
Pathogenic pathways of renal damage in Fabry nephropathy: interplay between immune cell infiltration, apoptosis and fibrosis.
J Nephrol
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512375
20.
Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond.
Clin Kidney J
; 17(1): sfad228, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213493